Here's Why Pacific Biosciences of California Is Falling Today [The Motley Fool]
Pacific Biosciences of California, Inc. (PACB)
Last pacific biosciences of california, inc. earnings: 2/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.pacificbiosciences.com
Company Research
Source: The Motley Fool
Disappointing quarterly results weighed on the stock. Cory Renauer ( TMFang4apples ) May 3, 2018 at 12:47PM What happened Shares of Pacific Biosciences of California ( NASDAQ:PACB ) , a genome sequencing equipment manufacturer, are under pressure following a disappointing first-quarter report. The stock was down 15.7% as of 12:04 p.m. EDT on Thursday. So what Consensus estimates were expecting a flat top line in the first quarter of 2018 due to a spike in shipments during the same period last year. Unfortunately, Pacific Biosciences of California wasn't able to ship quite a few systems during the first three months of 2018 because customers were still building facilities to house them. As a result, the company reported a disturbing 22% year-to-year plunge in first-quarter revenue. Image source: Getty Images. Quarterly lumpiness aside
Show less
Read more
Impact Snapshot
Event Time:
PACB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PACB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PACB alerts
High impacting Pacific Biosciences of California, Inc. news events
Weekly update
A roundup of the hottest topics
PACB
News
- PacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays [Yahoo! Finance]Yahoo! Finance
- PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance [Yahoo! Finance]Yahoo! Finance
- PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue GuidancePR Newswire
- Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Barclays PLC from $8.00 to $3.00. They now have an "equal weight" rating on the stock.MarketBeat
- Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $9.00 to $7.00. They now have a "buy" rating on the stock.MarketBeat
PACB
Earnings
- 2/15/24 - Beat
PACB
Sec Filings
- 4/16/24 - Form 8-K
- 4/15/24 - Form PRE
- 4/11/24 - Form POSASR
- PACB's page on the SEC website